Veru EPS - Earnings per Share 2012-2025 | VERU
Veru eps - earnings per share from 2012 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Veru Annual EPS | |
|---|---|
| 2025 | $-1.55 |
| 2024 | $-2.80 |
| 2023 | $-11.00 |
| 2022 | $-10.50 |
| 2021 | $0.90 |
| 2020 | $-2.80 |
| 2019 | $-1.90 |
| 2018 | $-4.40 |
| 2017 | $-2.50 |
| 2016 | $0.10 |
| 2015 | $1.50 |
| 2014 | $0.80 |
| 2013 | $5.00 |
| 2012 | $5.30 |
| 2011 | $1.90 |
| Veru Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.05 |
| 2025-06-30 | $-0.50 |
| 2025-03-31 | $-0.50 |
| 2024-12-31 | $-0.60 |
| 2024-09-30 | $-0.55 |
| 2024-06-30 | $-0.75 |
| 2024-03-31 | $-0.70 |
| 2023-12-31 | $-0.80 |
| 2023-09-30 | $-0.60 |
| 2023-06-30 | $-1.40 |
| 2023-03-31 | $-4.20 |
| 2022-12-31 | $-4.80 |
| 2022-09-30 | $-5.10 |
| 2022-06-30 | $-2.80 |
| 2022-03-31 | $-1.80 |
| 2021-12-31 | $-0.80 |
| 2021-09-30 | $-0.70 |
| 2021-06-30 | $-0.30 |
| 2021-03-31 | $-0.40 |
| 2020-12-31 | $2.30 |
| 2020-09-30 | $-1.70 |
| 2020-06-30 | $-0.50 |
| 2020-03-31 | $-0.10 |
| 2019-12-31 | $-0.50 |
| 2019-09-30 | $-0.60 |
| 2019-06-30 | $-0.40 |
| 2019-03-31 | $-0.60 |
| 2018-12-31 | $-0.30 |
| 2018-09-30 | $-1.40 |
| 2018-06-30 | $-1.50 |
| 2018-03-31 | $-0.70 |
| 2017-12-31 | $-0.80 |
| 2017-09-30 | $-1.20 |
| 2017-06-30 | $-0.30 |
| 2017-03-31 | $-0.60 |
| 2016-12-31 | $-0.40 |
| 2016-09-30 | $-0.60 |
| 2016-06-30 | $0.20 |
| 2016-03-31 | $0.00 |
| 2015-12-31 | $0.50 |
| 2015-09-30 | $0.20 |
| 2015-06-30 | $0.40 |
| 2015-03-31 | $0.60 |
| 2014-12-31 | $0.30 |
| 2014-09-30 | $-0.20 |
| 2014-06-30 | $0.40 |
| 2014-03-31 | $0.10 |
| 2013-12-31 | $0.50 |
| 2013-09-30 | $2.30 |
| 2013-06-30 | $0.30 |
| 2013-03-31 | $1.20 |
| 2012-12-31 | $1.20 |
| 2012-09-30 | $2.80 |
| 2012-06-30 | $0.90 |
| 2012-03-31 | $0.70 |
| 2011-12-31 | $0.90 |
| 2011-09-30 | $1.70 |
| 2011-06-30 | $0.10 |
| 2011-03-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.037B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $197.518B | 22.06 |
| EssilorLuxottica (ESLOY) | France | $154.739B | 0.00 |
| Stryker (SYK) | United States | $139.087B | 26.68 |
| Medtronic (MDT) | Ireland | $129.586B | 17.95 |
| Boston Scientific (BSX) | United States | $108.915B | 24.09 |
| Medline (MDLN) | United States | $59.170B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.091B | 0.00 |
| ResMed (RMD) | United States | $37.821B | 25.25 |
| Agilent Technologies (A) | United States | $36.458B | 23.10 |
| GE HealthCare Technologies (GEHC) | United States | $36.095B | 17.29 |
| Koninklijke Philips (PHG) | Netherlands | $30.881B | 18.33 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 11.66 |
| Insulet (PODD) | United States | $17.647B | 54.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.998B | 0.00 |
| Baxter (BAX) | United States | $11.448B | 9.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.922B | 28.49 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.976B | 25.22 |
| Lantheus Holdings (LNTH) | United States | $4.461B | 13.59 |
| BillionToOne (BLLN) | United States | $3.924B | 0.00 |
| ICU Medical (ICUI) | United States | $3.647B | 23.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.122B | 14.73 |
| Haemonetics (HAE) | United States | $2.672B | 11.69 |
| Neogen (NEOG) | United States | $2.338B | 51.19 |
| Phibro Animal Health (PAHC) | United States | $2.088B | 18.40 |
| Perrigo (PRGO) | Ireland | $2.009B | 5.03 |
| LeMaitre Vascular (LMAT) | United States | $1.991B | 40.08 |
| QuidelOrtho (QDEL) | United States | $1.956B | 13.59 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.625B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Green Thumb Industries (GTBIF) | United States | $1.390B | 60.91 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.304B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.071B | 317.86 |
| InMode (INMD) | Israel | $0.902B | 9.89 |
| Tilray Brands (TLRY) | Canada | $0.888B | 0.00 |
| Valneva SE (VALN) | France | $0.834B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.763B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.570B | 13.61 |
| Brainsway (BWAY) | Israel | $0.459B | 78.10 |
| Verano Holdings (VRNO) | United States | $0.432B | 0.00 |
| Cerus (CERS) | United States | $0.413B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| Quanterix (QTRX) | United States | $0.279B | 0.00 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.240B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.212B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 18.45 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.195B | 57.33 |
| TerrAscend (TSNDF) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.74 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 24.96 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 31.08 |
| Cytosorbents (CTSO) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.40 |
| Jin Medical (ZJYL) | China | $0.025B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |